Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing On Dashboard
August 11, 2021 08:30 ET
|
Ehave
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
Ehave Partners with Globally Recognized University to Target Hallucinogen Persisting Perception Disorder (HPPD)
August 04, 2021 08:30 ET
|
Ehave
MIAMI, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today announced a...
Hallucinogen Persisting Perception Disorder (HPPD) Research Initiated By Ehave
July 29, 2021 08:30 ET
|
Ehave
HPPD is a psychiatric disorder characterized by the persisting presence of sensory disturbances, most commonly visual, that resemble those produced by the use of hallucinogenic substances. Ehave...
Ehave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands Capabilities
July 13, 2021 08:30 ET
|
Ehave
MIAMI, July 13, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced a partnership with...
Ehave Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness Launching Ketamine Clinical Trials In Miami
July 09, 2021 09:30 ET
|
Ehave
MIAMI, July 09, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company...
Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board
July 06, 2021 08:30 ET
|
Ehave
MIAMI, July 06, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Bankole...
Mycotopia Therapies PsyTech Inc. Announces Third Annual Psytech Summit on July 19th and 20th, 2021
July 02, 2021 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) (the “Company”) announced today an upcoming complimentary Psychedelic Industry summit will take place virtually...
Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021
July 02, 2021 08:30 ET
|
Ehave
MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it will be...
Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical Platforms
June 29, 2021 08:30 ET
|
Ehave
MIAMI, June 29, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Nitin...
InvestorBrandNetwork (IBN) and PsychedelicNewsWire (PNW) Announce Collaboration with Microdose Psychedelic Insights for the upcoming June Conferences
June 11, 2021 13:46 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, today announces that it will be...